{
  "id": 10478289,
  "title": "Scynexis' BARDA alliance; Bristol Myers' early data for dual-targeting CAR-T",
  "url": "https://urgent.news/2026/09/28/scynexis-barda-alliance-bristol-myers-early-data-for-dual-targeting",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-28T15:22:04.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/scynexis-barda-alliance-bristol-myers-early-data-for-dual-targeting-car-t/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Plus, news about MediciNova, Tolerance Bio, Tanabe, Lepu Medical and Synphatec. Scynexis’ $200M+ BARDA contract: The partnership is for SCY-247, an investigational treatment for serious drug-resistant fungal infections. The pact is ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}